Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus

Identifieur interne : 000278 ( PascalFrancis/Corpus ); précédent : 000277; suivant : 000279

Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus

Auteurs : John T. Cacioppo ; Janice K. Kiecolt-Glaser ; William B. Malarkey ; Bryon F. Laskowski ; Leigh Ann Rozlog ; Kirsten M. Poehlmann ; Mary H. Burleson ; Ronald Glaser

Source :

RBID : Pascal:02-0546905

Descripteurs français

English descriptors

Abstract

Previous studies have demonstrated the impact of psychological stress on the steady-state expression/reactivation of latent Epstein-Barr virus (EBV). Stress-induced decrements in the cellular immune response result in less control over the expression of the latent virus, resulting in increases in antibody to the virus. In Study 1, we investigated whether the steady-state expression of latent EBV in vivo differed between high and low stress reactors, as defined by sympathetic cardiac reactivity. Autonomic activity and antibody titers to Epstein-Barr virus capsid antigen (VCA) were measured in 50 elderly women latently infected with EBV. Results revealed that women who were high stress reactors were characterized by higher antibody titers to the latent virus than low stress reactors. High reactors tended to show larger stress-related increases in cortisol than low reactors, but the differences were not significant. Daily stressors can activate the autonomic nervous system and promote the release of pituitary and adrenal hormones, especially in high reactors. Glucocorticoid hormones have been shown to reactivate EBV in vitro from cells latently infected with the virus. We hypothesized that absolute levels of plasma cortisol may not be the only explanation for stress-induced reactivation of latent EBV and that the diurnal changes in the production of cortisol may be an important factor in these interactions. To examine the feasibility of this hypothesis, an in vitro study was conducted (Study 2) to determine whether changing glucocorticoid concentrations in the medium, in which EBV latently infected cells were culture, to mimic diurnal changes in plasma cortisol concentrations would enhance the reactivation of the latent virus. Cells latently infected with EBV were exposed to either constant or varying concentrations of the synthetic glucocorticoid hormone dexamethasone (Dex), for 72 h. Results revealed a three- to eightfold enhancement of reactivation of latent EBV in cells pulsed with varying Dex concentrations when compared with cells exposed to a constant and/or a higher mean level of one Dex concentration. Together, these studies raise the possibility that differences in the kinetics of glucocorticoid concentrations may contribute to differences in the reactivation of latent EBV.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0018-506X
A02 01      @0 HOBEAO
A03   1    @0 Horm. behav.
A05       @2 42
A06       @2 1
A08 01  1  ENG  @1 Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus
A11 01  1    @1 CACIOPPO (John T.)
A11 02  1    @1 KIECOLT-GLASER (Janice K.)
A11 03  1    @1 MALARKEY (William B.)
A11 04  1    @1 LASKOWSKI (Bryon F.)
A11 05  1    @1 ROZLOG (Leigh Ann)
A11 06  1    @1 POEHLMANN (Kirsten M.)
A11 07  1    @1 BURLESON (Mary H.)
A11 08  1    @1 GLASER (Ronald)
A14 01      @1 University of Chicago @2 Chicago, Illinois @3 USA @Z 1 aut.
A14 02      @1 Ohio State University College of Medicine @2 Ohio @3 USA @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 8 aut.
A14 03      @1 University of Houston @2 Houston, Texas @3 USA @Z 6 aut.
A14 04      @1 Arizona State University @2 Tempe, Arizona @3 USA @Z 7 aut.
A20       @1 32-41
A21       @1 2002
A23 01      @0 ENG
A43 01      @1 INIST @2 14364 @5 354000109242160040
A44       @0 0000 @1 © 2002 INIST-CNRS. All rights reserved.
A45       @0 1 p.1/4
A47 01  1    @0 02-0546905
A60       @1 P
A61       @0 A
A64 01  1    @0 Hormones and behavior
A66 01      @0 USA
C01 01    ENG  @0 Previous studies have demonstrated the impact of psychological stress on the steady-state expression/reactivation of latent Epstein-Barr virus (EBV). Stress-induced decrements in the cellular immune response result in less control over the expression of the latent virus, resulting in increases in antibody to the virus. In Study 1, we investigated whether the steady-state expression of latent EBV in vivo differed between high and low stress reactors, as defined by sympathetic cardiac reactivity. Autonomic activity and antibody titers to Epstein-Barr virus capsid antigen (VCA) were measured in 50 elderly women latently infected with EBV. Results revealed that women who were high stress reactors were characterized by higher antibody titers to the latent virus than low stress reactors. High reactors tended to show larger stress-related increases in cortisol than low reactors, but the differences were not significant. Daily stressors can activate the autonomic nervous system and promote the release of pituitary and adrenal hormones, especially in high reactors. Glucocorticoid hormones have been shown to reactivate EBV in vitro from cells latently infected with the virus. We hypothesized that absolute levels of plasma cortisol may not be the only explanation for stress-induced reactivation of latent EBV and that the diurnal changes in the production of cortisol may be an important factor in these interactions. To examine the feasibility of this hypothesis, an in vitro study was conducted (Study 2) to determine whether changing glucocorticoid concentrations in the medium, in which EBV latently infected cells were culture, to mimic diurnal changes in plasma cortisol concentrations would enhance the reactivation of the latent virus. Cells latently infected with EBV were exposed to either constant or varying concentrations of the synthetic glucocorticoid hormone dexamethasone (Dex), for 72 h. Results revealed a three- to eightfold enhancement of reactivation of latent EBV in cells pulsed with varying Dex concentrations when compared with cells exposed to a constant and/or a higher mean level of one Dex concentration. Together, these studies raise the possibility that differences in the kinetics of glucocorticoid concentrations may contribute to differences in the reactivation of latent EBV.
C02 01  X    @0 002A26C08
C02 02  X    @0 002A26C03
C02 03  X    @0 002A26G08
C03 01  X  FRE  @0 Femelle @5 01
C03 01  X  ENG  @0 Female @5 01
C03 01  X  SPA  @0 Hembra @5 01
C03 02  X  FRE  @0 Virus Epstein Barr @2 NW @5 02
C03 02  X  ENG  @0 Epstein Barr virus @2 NW @5 02
C03 02  X  SPA  @0 Epstein Barr virus @2 NW @5 02
C03 03  X  FRE  @0 Immunité cellulaire @5 03
C03 03  X  ENG  @0 Cellular immunity @5 03
C03 03  X  SPA  @0 Inmunidad celular @5 03
C03 04  X  FRE  @0 ACTH @2 NK @5 04
C03 04  X  ENG  @0 Adrenocorticotropic hormone @2 NK @5 04
C03 04  X  SPA  @0 ACTH @2 NK @5 04
C03 05  X  FRE  @0 Hydrocortisone @2 NK @2 FR @5 05
C03 05  X  ENG  @0 Hydrocortisone @2 NK @2 FR @5 05
C03 05  X  SPA  @0 Hidrocortisona @2 NK @2 FR @5 05
C03 06  X  FRE  @0 Noradrénaline @2 NK @5 06
C03 06  X  ENG  @0 Norepinephrine @2 NK @5 06
C03 06  X  SPA  @0 Noradrenalina @2 NK @5 06
C03 07  X  FRE  @0 Stress @5 07
C03 07  X  ENG  @0 Stress @5 07
C03 07  X  SPA  @0 Estrés @5 07
C03 08  X  FRE  @0 Système nerveux autonome @5 08
C03 08  X  ENG  @0 Autonomic nervous system @5 08
C03 08  X  SPA  @0 Sistema nervioso autónomo @5 08
C03 09  X  FRE  @0 Homme @5 54
C03 09  X  ENG  @0 Human @5 54
C03 09  X  SPA  @0 Hombre @5 54
C03 10  X  FRE  @0 Adrénaline @2 NK @5 57
C03 10  X  ENG  @0 Epinephrine @2 NK @5 57
C03 10  X  SPA  @0 Adrenalina @2 NK @5 57
C03 11  X  FRE  @0 Réponse immune @5 60
C03 11  X  ENG  @0 Immune response @5 60
C03 11  X  SPA  @0 Respuesta inmune @5 60
C07 01  X  FRE  @0 Gammaherpesvirinae @2 NW
C07 01  X  ENG  @0 Gammaherpesvirinae @2 NW
C07 01  X  SPA  @0 Gammaherpesvirinae @2 NW
C07 02  X  FRE  @0 Herpesviridae @2 NW
C07 02  X  ENG  @0 Herpesviridae @2 NW
C07 02  X  SPA  @0 Herpesviridae @2 NW
C07 03  X  FRE  @0 Virus @2 NW
C07 03  X  ENG  @0 Virus @2 NW
C07 03  X  SPA  @0 Virus @2 NW
C07 04  X  FRE  @0 Hormone adénohypophysaire @5 29
C07 04  X  ENG  @0 Adenohypophyseal hormone @5 29
C07 04  X  SPA  @0 Hormona adenohipofisaria @5 29
C07 05  X  FRE  @0 Glucocorticoïde @5 32
C07 05  X  ENG  @0 Glucocorticoid @5 32
C07 05  X  SPA  @0 Glucocorticoide @5 32
C07 06  X  FRE  @0 Hormone surrénalienne @5 33
C07 06  X  ENG  @0 Adrenal hormone @5 33
C07 06  X  SPA  @0 Hormona suprarrenal @5 33
C07 07  X  FRE  @0 Catécholamine @5 35
C07 07  X  ENG  @0 Catecholamine @5 35
C07 07  X  SPA  @0 Catecolamina @5 35
N21       @1 322
N82       @1 PSI

Format Inist (serveur)

NO : PASCAL 02-0546905 INIST
ET : Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus
AU : CACIOPPO (John T.); KIECOLT-GLASER (Janice K.); MALARKEY (William B.); LASKOWSKI (Bryon F.); ROZLOG (Leigh Ann); POEHLMANN (Kirsten M.); BURLESON (Mary H.); GLASER (Ronald)
AF : University of Chicago/Chicago, Illinois/Etats-Unis (1 aut.); Ohio State University College of Medicine/Ohio/Etats-Unis (2 aut., 3 aut., 4 aut., 5 aut., 8 aut.); University of Houston/Houston, Texas/Etats-Unis (6 aut.); Arizona State University/Tempe, Arizona/Etats-Unis (7 aut.)
DT : Publication en série; Niveau analytique
SO : Hormones and behavior; ISSN 0018-506X; Coden HOBEAO; Etats-Unis; Da. 2002; Vol. 42; No. 1; Pp. 32-41; Bibl. 1 p.1/4
LA : Anglais
EA : Previous studies have demonstrated the impact of psychological stress on the steady-state expression/reactivation of latent Epstein-Barr virus (EBV). Stress-induced decrements in the cellular immune response result in less control over the expression of the latent virus, resulting in increases in antibody to the virus. In Study 1, we investigated whether the steady-state expression of latent EBV in vivo differed between high and low stress reactors, as defined by sympathetic cardiac reactivity. Autonomic activity and antibody titers to Epstein-Barr virus capsid antigen (VCA) were measured in 50 elderly women latently infected with EBV. Results revealed that women who were high stress reactors were characterized by higher antibody titers to the latent virus than low stress reactors. High reactors tended to show larger stress-related increases in cortisol than low reactors, but the differences were not significant. Daily stressors can activate the autonomic nervous system and promote the release of pituitary and adrenal hormones, especially in high reactors. Glucocorticoid hormones have been shown to reactivate EBV in vitro from cells latently infected with the virus. We hypothesized that absolute levels of plasma cortisol may not be the only explanation for stress-induced reactivation of latent EBV and that the diurnal changes in the production of cortisol may be an important factor in these interactions. To examine the feasibility of this hypothesis, an in vitro study was conducted (Study 2) to determine whether changing glucocorticoid concentrations in the medium, in which EBV latently infected cells were culture, to mimic diurnal changes in plasma cortisol concentrations would enhance the reactivation of the latent virus. Cells latently infected with EBV were exposed to either constant or varying concentrations of the synthetic glucocorticoid hormone dexamethasone (Dex), for 72 h. Results revealed a three- to eightfold enhancement of reactivation of latent EBV in cells pulsed with varying Dex concentrations when compared with cells exposed to a constant and/or a higher mean level of one Dex concentration. Together, these studies raise the possibility that differences in the kinetics of glucocorticoid concentrations may contribute to differences in the reactivation of latent EBV.
CC : 002A26C08; 002A26C03; 002A26G08
FD : Femelle; Virus Epstein Barr; Immunité cellulaire; ACTH; Hydrocortisone; Noradrénaline; Stress; Système nerveux autonome; Homme; Adrénaline; Réponse immune
FG : Gammaherpesvirinae; Herpesviridae; Virus; Hormone adénohypophysaire; Glucocorticoïde; Hormone surrénalienne; Catécholamine
ED : Female; Epstein Barr virus; Cellular immunity; Adrenocorticotropic hormone; Hydrocortisone; Norepinephrine; Stress; Autonomic nervous system; Human; Epinephrine; Immune response
EG : Gammaherpesvirinae; Herpesviridae; Virus; Adenohypophyseal hormone; Glucocorticoid; Adrenal hormone; Catecholamine
SD : Hembra; Epstein Barr virus; Inmunidad celular; ACTH; Hidrocortisona; Noradrenalina; Estrés; Sistema nervioso autónomo; Hombre; Adrenalina; Respuesta inmune
LO : INIST-14364.354000109242160040
ID : 02-0546905

Links to Exploration step

Pascal:02-0546905

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus</title>
<author>
<name sortKey="Cacioppo, John T" sort="Cacioppo, John T" uniqKey="Cacioppo J" first="John T." last="Cacioppo">John T. Cacioppo</name>
<affiliation>
<inist:fA14 i1="01">
<s1>University of Chicago</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kiecolt Glaser, Janice K" sort="Kiecolt Glaser, Janice K" uniqKey="Kiecolt Glaser J" first="Janice K." last="Kiecolt-Glaser">Janice K. Kiecolt-Glaser</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Malarkey, William B" sort="Malarkey, William B" uniqKey="Malarkey W" first="William B." last="Malarkey">William B. Malarkey</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Laskowski, Bryon F" sort="Laskowski, Bryon F" uniqKey="Laskowski B" first="Bryon F." last="Laskowski">Bryon F. Laskowski</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rozlog, Leigh Ann" sort="Rozlog, Leigh Ann" uniqKey="Rozlog L" first="Leigh Ann" last="Rozlog">Leigh Ann Rozlog</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Poehlmann, Kirsten M" sort="Poehlmann, Kirsten M" uniqKey="Poehlmann K" first="Kirsten M." last="Poehlmann">Kirsten M. Poehlmann</name>
<affiliation>
<inist:fA14 i1="03">
<s1>University of Houston</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Burleson, Mary H" sort="Burleson, Mary H" uniqKey="Burleson M" first="Mary H." last="Burleson">Mary H. Burleson</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Arizona State University</s1>
<s2>Tempe, Arizona</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Glaser, Ronald" sort="Glaser, Ronald" uniqKey="Glaser R" first="Ronald" last="Glaser">Ronald Glaser</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">02-0546905</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0546905 INIST</idno>
<idno type="RBID">Pascal:02-0546905</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000278</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus</title>
<author>
<name sortKey="Cacioppo, John T" sort="Cacioppo, John T" uniqKey="Cacioppo J" first="John T." last="Cacioppo">John T. Cacioppo</name>
<affiliation>
<inist:fA14 i1="01">
<s1>University of Chicago</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kiecolt Glaser, Janice K" sort="Kiecolt Glaser, Janice K" uniqKey="Kiecolt Glaser J" first="Janice K." last="Kiecolt-Glaser">Janice K. Kiecolt-Glaser</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Malarkey, William B" sort="Malarkey, William B" uniqKey="Malarkey W" first="William B." last="Malarkey">William B. Malarkey</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Laskowski, Bryon F" sort="Laskowski, Bryon F" uniqKey="Laskowski B" first="Bryon F." last="Laskowski">Bryon F. Laskowski</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rozlog, Leigh Ann" sort="Rozlog, Leigh Ann" uniqKey="Rozlog L" first="Leigh Ann" last="Rozlog">Leigh Ann Rozlog</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Poehlmann, Kirsten M" sort="Poehlmann, Kirsten M" uniqKey="Poehlmann K" first="Kirsten M." last="Poehlmann">Kirsten M. Poehlmann</name>
<affiliation>
<inist:fA14 i1="03">
<s1>University of Houston</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Burleson, Mary H" sort="Burleson, Mary H" uniqKey="Burleson M" first="Mary H." last="Burleson">Mary H. Burleson</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Arizona State University</s1>
<s2>Tempe, Arizona</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Glaser, Ronald" sort="Glaser, Ronald" uniqKey="Glaser R" first="Ronald" last="Glaser">Ronald Glaser</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Hormones and behavior</title>
<title level="j" type="abbreviated">Horm. behav.</title>
<idno type="ISSN">0018-506X</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Hormones and behavior</title>
<title level="j" type="abbreviated">Horm. behav.</title>
<idno type="ISSN">0018-506X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adrenocorticotropic hormone</term>
<term>Autonomic nervous system</term>
<term>Cellular immunity</term>
<term>Epinephrine</term>
<term>Epstein Barr virus</term>
<term>Female</term>
<term>Human</term>
<term>Hydrocortisone</term>
<term>Immune response</term>
<term>Norepinephrine</term>
<term>Stress</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Femelle</term>
<term>Virus Epstein Barr</term>
<term>Immunité cellulaire</term>
<term>ACTH</term>
<term>Hydrocortisone</term>
<term>Noradrénaline</term>
<term>Stress</term>
<term>Système nerveux autonome</term>
<term>Homme</term>
<term>Adrénaline</term>
<term>Réponse immune</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Previous studies have demonstrated the impact of psychological stress on the steady-state expression/reactivation of latent Epstein-Barr virus (EBV). Stress-induced decrements in the cellular immune response result in less control over the expression of the latent virus, resulting in increases in antibody to the virus. In Study 1, we investigated whether the steady-state expression of latent EBV in vivo differed between high and low stress reactors, as defined by sympathetic cardiac reactivity. Autonomic activity and antibody titers to Epstein-Barr virus capsid antigen (VCA) were measured in 50 elderly women latently infected with EBV. Results revealed that women who were high stress reactors were characterized by higher antibody titers to the latent virus than low stress reactors. High reactors tended to show larger stress-related increases in cortisol than low reactors, but the differences were not significant. Daily stressors can activate the autonomic nervous system and promote the release of pituitary and adrenal hormones, especially in high reactors. Glucocorticoid hormones have been shown to reactivate EBV in vitro from cells latently infected with the virus. We hypothesized that absolute levels of plasma cortisol may not be the only explanation for stress-induced reactivation of latent EBV and that the diurnal changes in the production of cortisol may be an important factor in these interactions. To examine the feasibility of this hypothesis, an in vitro study was conducted (Study 2) to determine whether changing glucocorticoid concentrations in the medium, in which EBV latently infected cells were culture, to mimic diurnal changes in plasma cortisol concentrations would enhance the reactivation of the latent virus. Cells latently infected with EBV were exposed to either constant or varying concentrations of the synthetic glucocorticoid hormone dexamethasone (Dex), for 72 h. Results revealed a three- to eightfold enhancement of reactivation of latent EBV in cells pulsed with varying Dex concentrations when compared with cells exposed to a constant and/or a higher mean level of one Dex concentration. Together, these studies raise the possibility that differences in the kinetics of glucocorticoid concentrations may contribute to differences in the reactivation of latent EBV.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0018-506X</s0>
</fA01>
<fA02 i1="01">
<s0>HOBEAO</s0>
</fA02>
<fA03 i2="1">
<s0>Horm. behav.</s0>
</fA03>
<fA05>
<s2>42</s2>
</fA05>
<fA06>
<s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>CACIOPPO (John T.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>KIECOLT-GLASER (Janice K.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>MALARKEY (William B.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>LASKOWSKI (Bryon F.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>ROZLOG (Leigh Ann)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>POEHLMANN (Kirsten M.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>BURLESON (Mary H.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>GLASER (Ronald)</s1>
</fA11>
<fA14 i1="01">
<s1>University of Chicago</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Ohio State University College of Medicine</s1>
<s2>Ohio</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>University of Houston</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Arizona State University</s1>
<s2>Tempe, Arizona</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>32-41</s1>
</fA20>
<fA21>
<s1>2002</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>14364</s2>
<s5>354000109242160040</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2002 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>1 p.1/4</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>02-0546905</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Hormones and behavior</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Previous studies have demonstrated the impact of psychological stress on the steady-state expression/reactivation of latent Epstein-Barr virus (EBV). Stress-induced decrements in the cellular immune response result in less control over the expression of the latent virus, resulting in increases in antibody to the virus. In Study 1, we investigated whether the steady-state expression of latent EBV in vivo differed between high and low stress reactors, as defined by sympathetic cardiac reactivity. Autonomic activity and antibody titers to Epstein-Barr virus capsid antigen (VCA) were measured in 50 elderly women latently infected with EBV. Results revealed that women who were high stress reactors were characterized by higher antibody titers to the latent virus than low stress reactors. High reactors tended to show larger stress-related increases in cortisol than low reactors, but the differences were not significant. Daily stressors can activate the autonomic nervous system and promote the release of pituitary and adrenal hormones, especially in high reactors. Glucocorticoid hormones have been shown to reactivate EBV in vitro from cells latently infected with the virus. We hypothesized that absolute levels of plasma cortisol may not be the only explanation for stress-induced reactivation of latent EBV and that the diurnal changes in the production of cortisol may be an important factor in these interactions. To examine the feasibility of this hypothesis, an in vitro study was conducted (Study 2) to determine whether changing glucocorticoid concentrations in the medium, in which EBV latently infected cells were culture, to mimic diurnal changes in plasma cortisol concentrations would enhance the reactivation of the latent virus. Cells latently infected with EBV were exposed to either constant or varying concentrations of the synthetic glucocorticoid hormone dexamethasone (Dex), for 72 h. Results revealed a three- to eightfold enhancement of reactivation of latent EBV in cells pulsed with varying Dex concentrations when compared with cells exposed to a constant and/or a higher mean level of one Dex concentration. Together, these studies raise the possibility that differences in the kinetics of glucocorticoid concentrations may contribute to differences in the reactivation of latent EBV.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A26C08</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002A26C03</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002A26G08</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Femelle</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Female</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Hembra</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Virus Epstein Barr</s0>
<s2>NW</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Epstein Barr virus</s0>
<s2>NW</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Epstein Barr virus</s0>
<s2>NW</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Immunité cellulaire</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Cellular immunity</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Inmunidad celular</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>ACTH</s0>
<s2>NK</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Adrenocorticotropic hormone</s0>
<s2>NK</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>ACTH</s0>
<s2>NK</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Hydrocortisone</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Hydrocortisone</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Hidrocortisona</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Noradrénaline</s0>
<s2>NK</s2>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Norepinephrine</s0>
<s2>NK</s2>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Noradrenalina</s0>
<s2>NK</s2>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Stress</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Stress</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Estrés</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Système nerveux autonome</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Autonomic nervous system</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Sistema nervioso autónomo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Homme</s0>
<s5>54</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Human</s0>
<s5>54</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>54</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Adrénaline</s0>
<s2>NK</s2>
<s5>57</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Epinephrine</s0>
<s2>NK</s2>
<s5>57</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Adrenalina</s0>
<s2>NK</s2>
<s5>57</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Réponse immune</s0>
<s5>60</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Immune response</s0>
<s5>60</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Respuesta inmune</s0>
<s5>60</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Gammaherpesvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Gammaherpesvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Gammaherpesvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Herpesviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Herpesviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Herpesviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Hormone adénohypophysaire</s0>
<s5>29</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Adenohypophyseal hormone</s0>
<s5>29</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Hormona adenohipofisaria</s0>
<s5>29</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Glucocorticoïde</s0>
<s5>32</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Glucocorticoid</s0>
<s5>32</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Glucocorticoide</s0>
<s5>32</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Hormone surrénalienne</s0>
<s5>33</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Adrenal hormone</s0>
<s5>33</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Hormona suprarrenal</s0>
<s5>33</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Catécholamine</s0>
<s5>35</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Catecholamine</s0>
<s5>35</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Catecolamina</s0>
<s5>35</s5>
</fC07>
<fN21>
<s1>322</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 02-0546905 INIST</NO>
<ET>Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus</ET>
<AU>CACIOPPO (John T.); KIECOLT-GLASER (Janice K.); MALARKEY (William B.); LASKOWSKI (Bryon F.); ROZLOG (Leigh Ann); POEHLMANN (Kirsten M.); BURLESON (Mary H.); GLASER (Ronald)</AU>
<AF>University of Chicago/Chicago, Illinois/Etats-Unis (1 aut.); Ohio State University College of Medicine/Ohio/Etats-Unis (2 aut., 3 aut., 4 aut., 5 aut., 8 aut.); University of Houston/Houston, Texas/Etats-Unis (6 aut.); Arizona State University/Tempe, Arizona/Etats-Unis (7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Hormones and behavior; ISSN 0018-506X; Coden HOBEAO; Etats-Unis; Da. 2002; Vol. 42; No. 1; Pp. 32-41; Bibl. 1 p.1/4</SO>
<LA>Anglais</LA>
<EA>Previous studies have demonstrated the impact of psychological stress on the steady-state expression/reactivation of latent Epstein-Barr virus (EBV). Stress-induced decrements in the cellular immune response result in less control over the expression of the latent virus, resulting in increases in antibody to the virus. In Study 1, we investigated whether the steady-state expression of latent EBV in vivo differed between high and low stress reactors, as defined by sympathetic cardiac reactivity. Autonomic activity and antibody titers to Epstein-Barr virus capsid antigen (VCA) were measured in 50 elderly women latently infected with EBV. Results revealed that women who were high stress reactors were characterized by higher antibody titers to the latent virus than low stress reactors. High reactors tended to show larger stress-related increases in cortisol than low reactors, but the differences were not significant. Daily stressors can activate the autonomic nervous system and promote the release of pituitary and adrenal hormones, especially in high reactors. Glucocorticoid hormones have been shown to reactivate EBV in vitro from cells latently infected with the virus. We hypothesized that absolute levels of plasma cortisol may not be the only explanation for stress-induced reactivation of latent EBV and that the diurnal changes in the production of cortisol may be an important factor in these interactions. To examine the feasibility of this hypothesis, an in vitro study was conducted (Study 2) to determine whether changing glucocorticoid concentrations in the medium, in which EBV latently infected cells were culture, to mimic diurnal changes in plasma cortisol concentrations would enhance the reactivation of the latent virus. Cells latently infected with EBV were exposed to either constant or varying concentrations of the synthetic glucocorticoid hormone dexamethasone (Dex), for 72 h. Results revealed a three- to eightfold enhancement of reactivation of latent EBV in cells pulsed with varying Dex concentrations when compared with cells exposed to a constant and/or a higher mean level of one Dex concentration. Together, these studies raise the possibility that differences in the kinetics of glucocorticoid concentrations may contribute to differences in the reactivation of latent EBV.</EA>
<CC>002A26C08; 002A26C03; 002A26G08</CC>
<FD>Femelle; Virus Epstein Barr; Immunité cellulaire; ACTH; Hydrocortisone; Noradrénaline; Stress; Système nerveux autonome; Homme; Adrénaline; Réponse immune</FD>
<FG>Gammaherpesvirinae; Herpesviridae; Virus; Hormone adénohypophysaire; Glucocorticoïde; Hormone surrénalienne; Catécholamine</FG>
<ED>Female; Epstein Barr virus; Cellular immunity; Adrenocorticotropic hormone; Hydrocortisone; Norepinephrine; Stress; Autonomic nervous system; Human; Epinephrine; Immune response</ED>
<EG>Gammaherpesvirinae; Herpesviridae; Virus; Adenohypophyseal hormone; Glucocorticoid; Adrenal hormone; Catecholamine</EG>
<SD>Hembra; Epstein Barr virus; Inmunidad celular; ACTH; Hidrocortisona; Noradrenalina; Estrés; Sistema nervioso autónomo; Hombre; Adrenalina; Respuesta inmune</SD>
<LO>INIST-14364.354000109242160040</LO>
<ID>02-0546905</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000278 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000278 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:02-0546905
   |texte=   Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021